Hong-Min Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hong-Min Lin has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Yu Chang
10 shared publicationsKuan-Yu Chi
7 shared publicationsChien-Min Chen
6 shared publications- Yu Chang
Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
6 shared publications Junmin Song
Jacobi Medical Center
4 shared publications- Kuan-Yu Chi
Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA
4 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Elsevier in World Neurosurgery
Dementia Risk After Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture: A Propensity Score-Matched Cohort Study
- 5 November 2026
- Published by Elsevier in World Neurosurgery
Open AccessDementia Risk After Vertebral Augmentation for Osteoporotic Vertebral Compression Fracture: A Propensity Score-Matched Cohort Study
- 19 October 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
Perioperative Hyperlactatemia in Brain Tumor Craniotomy Is Not Always a Warning Sign
Was not provided for this article.
- 19 October 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
Perioperative Hyperlactatemia in Brain Tumor Craniotomy Is Not Always a Warning Sign
Was not provided for this article.
- 16 October 2026
- Published by Springer Nature in Acta Diabetologica
- p. 1-9
GLP-1 receptor agonist use and contrast-associated acute kidney injury after contrast-enhanced CT and CT angiography in adults with type 2 diabetes and chronic kidney disease: a propensity score-matched cohort study
Aims To examine whether glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with contrast-associated acute kidney injury (CA-AKI) after contrast-enhanced computed tomography (CE-CT) or computed tomographic angiography (CTA) in adults with type 2 diabetes and chronic kidney disease (CKD). Methods We conducted a TriNetX retrospective cohort study of adults with type 2 diabetes and CKD who underwent CE-CT or CTA from January 2020 to January 2025. GLP-1 RA use was defined by a prescription within six months before imaging. The primary outcome was a new acute kidney injury diagnosis within three days. Separate 1:1 propensity score-matched analyses were conducted for CE-CT and CTA, with eGFR-stratified and sensitivity analyses. Results After matching, the CE-CT and CTA cohorts included 6,995 and 3,285 pairs, respectively. CA-AKI occurred in 3.8% of GLP-1 RA users versus 4.5% of non-users after CE-CT (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.71–0.99) and in 4.5% versus 6.1% after CTA (OR 0.74, 95% CI 0.59–0.92). The absolute risk differences were 0.7% points and 1.5% points, respectively. HbA1c remained imbalanced after matching. Negative-control outcomes were null, and eGFR-stratified associations were inconsistent between cohorts. Conclusions GLP-1 RA use was associated with a lower observed risk of CA-AKI after CE-CT and CTA in adults with type 2 diabetes and CKD. Residual HbA1c imbalance and the observational design limit causal interpretation; prospective studies using creatinine-based outcomes are needed.
- 16 October 2026
- Published by Springer Nature in Acta Diabetologica
- p. 1-9
GLP-1 receptor agonist use and contrast-associated acute kidney injury after contrast-enhanced CT and CT angiography in adults with type 2 diabetes and chronic kidney disease: a propensity score-matched cohort study
Aims To examine whether glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with contrast-associated acute kidney injury (CA-AKI) after contrast-enhanced computed tomography (CE-CT) or computed tomographic angiography (CTA) in adults with type 2 diabetes and chronic kidney disease (CKD). Methods We conducted a TriNetX retrospective cohort study of adults with type 2 diabetes and CKD who underwent CE-CT or CTA from January 2020 to January 2025. GLP-1 RA use was defined by a prescription within six months before imaging. The primary outcome was a new acute kidney injury diagnosis within three days. Separate 1:1 propensity score-matched analyses were conducted for CE-CT and CTA, with eGFR-stratified and sensitivity analyses. Results After matching, the CE-CT and CTA cohorts included 6,995 and 3,285 pairs, respectively. CA-AKI occurred in 3.8% of GLP-1 RA users versus 4.5% of non-users after CE-CT (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.71–0.99) and in 4.5% versus 6.1% after CTA (OR 0.74, 95% CI 0.59–0.92). The absolute risk differences were 0.7% points and 1.5% points, respectively. HbA1c remained imbalanced after matching. Negative-control outcomes were null, and eGFR-stratified associations were inconsistent between cohorts. Conclusions GLP-1 RA use was associated with a lower observed risk of CA-AKI after CE-CT and CTA in adults with type 2 diabetes and CKD. Residual HbA1c imbalance and the observational design limit causal interpretation; prospective studies using creatinine-based outcomes are needed.
- Open Access
- 15 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216, 125427
Recorded Osteoporosis and Subsequent Lumbar Fusion After Lumbar Decompression: A Propensity Score–Matched Cohort Study
- 15 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216, 125427
Open AccessRecorded Osteoporosis and Subsequent Lumbar Fusion After Lumbar Decompression: A Propensity Score–Matched Cohort Study
- Open Access
- 8 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Letter to the Editor Regarding “Functional Outcomes and Complications Following Very Delayed Cranioplasty: Clinical Challenges and Surgical Considerations”
- 8 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216
Open AccessLetter to the Editor Regarding “Functional Outcomes and Complications Following Very Delayed Cranioplasty: Clinical Challenges and Surgical Considerations”
- Open Access
- 21 August 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1893783
Brain dynamic audio stimulation for subjective sleep disturbances in healthcare professionals: a single-arm pilot feasibility study
Background: Insomnia and sleep disturbances are highly prevalent among healthcare professionals and pose risks to patient safety. Brain Dynamic Audio Stimulation (BDAS) is a non-invasive, open-loop auditory intervention intended to facilitate sleep initiation. This single-arm pilot feasibility study examined the feasibility and preliminary signal of a 14-day BDAS intervention in healthcare professionals with subjective sleep disturbances. Methods: Of 30 healthcare professionals assessed for eligibility, 15 were enrolled. Participants received one 30-min BDAS session nightly for 14 consecutive days. Insomnia severity was assessed using the Insomnia Severity Index (ISI) at baseline and Day 14. Short-duration EEG recordings (30 min, time-locked to BDAS, focused on sleep initiation) were obtained at both time points. Pre–post changes were analyzed using paired-sample tests; EEG outcomes were considered exploratory. Results: All 15 participants completed the intervention (100% retention; no adverse events). Mean ISI scores decreased from 10.00 (SD 5.55) to 4.27 (SD 2.69) (mean change −5.73; 95% CI − 8.15 to −3.32; Cohen’s d z = 1.31; p < 0.001). Exploratory EEG analyses showed reductions in sleep onset latency (828 s to 480 s; d z = 0.89; p = 0.004) and increases in 30-min sleep efficiency (34.8 to 46.8%; d z = 0.57; p = 0.045). All predefined feasibility progression criteria were met. Conclusion: BDAS demonstrated feasibility and acceptability in a healthcare professional setting. The observed within-participant improvements in insomnia severity and exploratory EEG parameters provide a preliminary signal and effect size estimates to inform future randomized controlled trials. Because the design was single-arm and uncontrolled, these within-participant changes cannot be attributed to BDAS specifically.
- 21 August 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1893783
Open AccessBrain dynamic audio stimulation for subjective sleep disturbances in healthcare professionals: a single-arm pilot feasibility study
Background: Insomnia and sleep disturbances are highly prevalent among healthcare professionals and pose risks to patient safety. Brain Dynamic Audio Stimulation (BDAS) is a non-invasive, open-loop auditory intervention intended to facilitate sleep initiation. This single-arm pilot feasibility study examined the feasibility and preliminary signal of a 14-day BDAS intervention in healthcare professionals with subjective sleep disturbances. Methods: Of 30 healthcare professionals assessed for eligibility, 15 were enrolled. Participants received one 30-min BDAS session nightly for 14 consecutive days. Insomnia severity was assessed using the Insomnia Severity Index (ISI) at baseline and Day 14. Short-duration EEG recordings (30 min, time-locked to BDAS, focused on sleep initiation) were obtained at both time points. Pre–post changes were analyzed using paired-sample tests; EEG outcomes were considered exploratory. Results: All 15 participants completed the intervention (100% retention; no adverse events). Mean ISI scores decreased from 10.00 (SD 5.55) to 4.27 (SD 2.69) (mean change −5.73; 95% CI − 8.15 to −3.32; Cohen’s d z = 1.31; p < 0.001). Exploratory EEG analyses showed reductions in sleep onset latency (828 s to 480 s; d z = 0.89; p = 0.004) and increases in 30-min sleep efficiency (34.8 to 46.8%; d z = 0.57; p = 0.045). All predefined feasibility progression criteria were met. Conclusion: BDAS demonstrated feasibility and acceptability in a healthcare professional setting. The observed within-participant improvements in insomnia severity and exploratory EEG parameters provide a preliminary signal and effect size estimates to inform future randomized controlled trials. Because the design was single-arm and uncontrolled, these within-participant changes cannot be attributed to BDAS specifically.
- Open Access
- 22 June 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Epidural steroid injections and vertebral fracture risk: a systematic review and meta-analysis
- 22 June 2026
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Open AccessEpidural steroid injections and vertebral fracture risk: a systematic review and meta-analysis
- 8 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 5428-5433
New-onset depression following anterior cervical discectomy and fusion or cervical artificial disc replacement: a retrospective cohort study using a multi-institutional claims database
Psychological outcomes after cervical spine surgery remain underexplored, particularly the development of new-onset depression. This study aimed to compare the long-term incidence of new-onset depression following anterior cervical discectomy and fusion (ACDF) versus cervical artificial disc replacement (ADR), hypothesizing that motion preservation with ADR may be associated with a lower risk of postoperative depression. We conducted a retrospective cohort study using the TriNetX Global Collaborative Network, including patients who underwent ACDF or ADR between 2005 and 2020. Patients with pre-existing mood disorders or prior antidepressant use were excluded. A 1:1 propensity score matching was performed based on demographics and baseline comorbidities. New-onset depression was identified using ICD-10 diagnoses and/or antidepressant prescriptions. Time-to-event analyses were conducted using Kaplan-Meier curves, and hazard ratios (HRs), absolute risk differences, and numbers needed to treat (NNTs) were calculated. At 5-year follow-up, ADR was associated with a significantly lower incidence of new-onset depression compared with ACDF (HR, 0.79; 95% CI, 0.72-0.87). The absolute risk difference was - 5.2%, corresponding to an NNT of 19. Consistent results were observed across alternative depression definitions. In this large real-world cohort, ADR was associated with a modest but clinically meaningful reduction in the risk of new-onset depression compared with ACDF. These findings are hypothesis-generating and should be interpreted with caution given the observational design and the potential for residual confounding. Further prospective studies incorporating patient-reported outcomes are warranted.
- 8 June 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (9) , 5428-5433
New-onset depression following anterior cervical discectomy and fusion or cervical artificial disc replacement: a retrospective cohort study using a multi-institutional claims database
Psychological outcomes after cervical spine surgery remain underexplored, particularly the development of new-onset depression. This study aimed to compare the long-term incidence of new-onset depression following anterior cervical discectomy and fusion (ACDF) versus cervical artificial disc replacement (ADR), hypothesizing that motion preservation with ADR may be associated with a lower risk of postoperative depression. We conducted a retrospective cohort study using the TriNetX Global Collaborative Network, including patients who underwent ACDF or ADR between 2005 and 2020. Patients with pre-existing mood disorders or prior antidepressant use were excluded. A 1:1 propensity score matching was performed based on demographics and baseline comorbidities. New-onset depression was identified using ICD-10 diagnoses and/or antidepressant prescriptions. Time-to-event analyses were conducted using Kaplan-Meier curves, and hazard ratios (HRs), absolute risk differences, and numbers needed to treat (NNTs) were calculated. At 5-year follow-up, ADR was associated with a significantly lower incidence of new-onset depression compared with ACDF (HR, 0.79; 95% CI, 0.72-0.87). The absolute risk difference was - 5.2%, corresponding to an NNT of 19. Consistent results were observed across alternative depression definitions. In this large real-world cohort, ADR was associated with a modest but clinically meaningful reduction in the risk of new-onset depression compared with ACDF. These findings are hypothesis-generating and should be interpreted with caution given the observational design and the potential for residual confounding. Further prospective studies incorporating patient-reported outcomes are warranted.
- Open Access
- 25 March 2026
- Published by Elsevier in World Neurosurgery
- Vol. 210, 124932
GLP-1 Receptor Agonists and Long-Term Survival after Spontaneous Intracerebral Hemorrhage in Type 2 Diabetes
- 25 March 2026
- Published by Elsevier in World Neurosurgery
- Vol. 210, 124932
Open AccessGLP-1 Receptor Agonists and Long-Term Survival after Spontaneous Intracerebral Hemorrhage in Type 2 Diabetes